There was no statistically significant difference of PSMA expression among FTC, PTC, RAI-refractive cancer and high-grade tumors (p = 0.58, Kruskal-Wallis test). The gene discussed is FOLH1; the disease is thyroid cancer, nonmedullary, 2.